This report aims to provide a comprehensive presentation of the global market for Repeat Expansion Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Repeat Expansion Disorders Treatment. This report contains market size and forecasts of Repeat Expansion Disorders Treatment in global, including the following market information:
Global Repeat Expansion Disorders Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Repeat Expansion Disorders Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Repeat Expansion Disorders Treatment include Pfizer, Inc., CRISPR Therapeutics, Acorda Therapeutics, Capsida Biotherapeutics Inc., Larimar Therapeutics, Inc., Healx, Intellia Therapeutics, Inc., Editas Medicine, Bluebird bio, Inc. and Sanofi, Merck & Co., Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Repeat Expansion Disorders Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Repeat Expansion Disorders Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Repeat Expansion Disorders Treatment Market Segment Percentages, by Type, 2022 (%)
Oral
Injection
Global Repeat Expansion Disorders Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Repeat Expansion Disorders Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Repeat Expansion Disorders Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Repeat Expansion Disorders Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Repeat Expansion Disorders Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Repeat Expansion Disorders Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
CRISPR Therapeutics
Acorda Therapeutics
Capsida Biotherapeutics Inc.
Larimar Therapeutics, Inc.
Healx, Intellia Therapeutics, Inc.
Editas Medicine
Bluebird bio, Inc.
Sanofi, Merck & Co., Inc.
H. Lundbeck A/S
Cellectis SA
Bio-Techne
GlaxoSmithKline plc
Allergan Aurobindo Pharma Ltd.
Sun Pharmaceutical Industries Ltd.
Torrent Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd.
Cipla Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Repeat Expansion Disorders Treatment, market overview.
Chapter 2: Global Repeat Expansion Disorders Treatment market size in revenue.
Chapter 3: Detailed analysis of Repeat Expansion Disorders Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Repeat Expansion Disorders Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Repeat Expansion Disorders Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Repeat Expansion Disorders Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Repeat Expansion Disorders Treatment Overall Market Size
2.1 Global Repeat Expansion Disorders Treatment Market Size: 2022 VS 2029
2.2 Global Repeat Expansion Disorders Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Repeat Expansion Disorders Treatment Players in Global Market
3.2 Top Global Repeat Expansion Disorders Treatment Companies Ranked by Revenue
3.3 Global Repeat Expansion Disorders Treatment Revenue by Companies
3.4 Top 3 and Top 5 Repeat Expansion Disorders Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Repeat Expansion Disorders Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Repeat Expansion Disorders Treatment Players in Global Market
3.6.1 List of Global Tier 1 Repeat Expansion Disorders Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Repeat Expansion Disorders Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Repeat Expansion Disorders Treatment Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injection
4.2 By Type - Global Repeat Expansion Disorders Treatment Revenue & Forecasts
4.2.1 By Type - Global Repeat Expansion Disorders Treatment Revenue, 2018-2023
4.2.2 By Type - Global Repeat Expansion Disorders Treatment Revenue, 2024-2029
4.2.3 By Type - Global Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Repeat Expansion Disorders Treatment Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Repeat Expansion Disorders Treatment Revenue & Forecasts
5.2.1 By Application - Global Repeat Expansion Disorders Treatment Revenue, 2018-2023
5.2.2 By Application - Global Repeat Expansion Disorders Treatment Revenue, 2024-2029
5.2.3 By Application - Global Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Repeat Expansion Disorders Treatment Market Size, 2022 & 2029
6.2 By Region - Global Repeat Expansion Disorders Treatment Revenue & Forecasts
6.2.1 By Region - Global Repeat Expansion Disorders Treatment Revenue, 2018-2023
6.2.2 By Region - Global Repeat Expansion Disorders Treatment Revenue, 2024-2029
6.2.3 By Region - Global Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Repeat Expansion Disorders Treatment Revenue, 2018-2029
6.3.2 US Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.3.3 Canada Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.3.4 Mexico Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Repeat Expansion Disorders Treatment Revenue, 2018-2029
6.4.2 Germany Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.4.3 France Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.4.4 U.K. Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.4.5 Italy Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.4.6 Russia Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.4.8 Benelux Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Repeat Expansion Disorders Treatment Revenue, 2018-2029
6.5.2 China Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.5.3 Japan Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.5.4 South Korea Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.5.6 India Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Repeat Expansion Disorders Treatment Revenue, 2018-2029
6.6.2 Brazil Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.6.3 Argentina Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Repeat Expansion Disorders Treatment Revenue, 2018-2029
6.7.2 Turkey Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.7.3 Israel Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Repeat Expansion Disorders Treatment Market Size, 2018-2029
6.7.5 UAE Repeat Expansion Disorders Treatment Market Size, 2018-2029
7 Repeat Expansion Disorders Treatment Companies Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Company Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Repeat Expansion Disorders Treatment Major Product Offerings
7.1.4 Pfizer, Inc. Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.1.5 Pfizer, Inc. Key News & Latest Developments
7.2 CRISPR Therapeutics
7.2.1 CRISPR Therapeutics Company Summary
7.2.2 CRISPR Therapeutics Business Overview
7.2.3 CRISPR Therapeutics Repeat Expansion Disorders Treatment Major Product Offerings
7.2.4 CRISPR Therapeutics Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.2.5 CRISPR Therapeutics Key News & Latest Developments
7.3 Acorda Therapeutics
7.3.1 Acorda Therapeutics Company Summary
7.3.2 Acorda Therapeutics Business Overview
7.3.3 Acorda Therapeutics Repeat Expansion Disorders Treatment Major Product Offerings
7.3.4 Acorda Therapeutics Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.3.5 Acorda Therapeutics Key News & Latest Developments
7.4 Capsida Biotherapeutics Inc.
7.4.1 Capsida Biotherapeutics Inc. Company Summary
7.4.2 Capsida Biotherapeutics Inc. Business Overview
7.4.3 Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Major Product Offerings
7.4.4 Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.4.5 Capsida Biotherapeutics Inc. Key News & Latest Developments
7.5 Larimar Therapeutics, Inc.
7.5.1 Larimar Therapeutics, Inc. Company Summary
7.5.2 Larimar Therapeutics, Inc. Business Overview
7.5.3 Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Major Product Offerings
7.5.4 Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.5.5 Larimar Therapeutics, Inc. Key News & Latest Developments
7.6 Healx, Intellia Therapeutics, Inc.
7.6.1 Healx, Intellia Therapeutics, Inc. Company Summary
7.6.2 Healx, Intellia Therapeutics, Inc. Business Overview
7.6.3 Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Major Product Offerings
7.6.4 Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.6.5 Healx, Intellia Therapeutics, Inc. Key News & Latest Developments
7.7 Editas Medicine
7.7.1 Editas Medicine Company Summary
7.7.2 Editas Medicine Business Overview
7.7.3 Editas Medicine Repeat Expansion Disorders Treatment Major Product Offerings
7.7.4 Editas Medicine Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.7.5 Editas Medicine Key News & Latest Developments
7.8 Bluebird bio, Inc.
7.8.1 Bluebird bio, Inc. Company Summary
7.8.2 Bluebird bio, Inc. Business Overview
7.8.3 Bluebird bio, Inc. Repeat Expansion Disorders Treatment Major Product Offerings
7.8.4 Bluebird bio, Inc. Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.8.5 Bluebird bio, Inc. Key News & Latest Developments
7.9 Sanofi, Merck & Co., Inc.
7.9.1 Sanofi, Merck & Co., Inc. Company Summary
7.9.2 Sanofi, Merck & Co., Inc. Business Overview
7.9.3 Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Major Product Offerings
7.9.4 Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.9.5 Sanofi, Merck & Co., Inc. Key News & Latest Developments
7.10 H. Lundbeck A/S
7.10.1 H. Lundbeck A/S Company Summary
7.10.2 H. Lundbeck A/S Business Overview
7.10.3 H. Lundbeck A/S Repeat Expansion Disorders Treatment Major Product Offerings
7.10.4 H. Lundbeck A/S Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.10.5 H. Lundbeck A/S Key News & Latest Developments
7.11 Cellectis SA
7.11.1 Cellectis SA Company Summary
7.11.2 Cellectis SA Business Overview
7.11.3 Cellectis SA Repeat Expansion Disorders Treatment Major Product Offerings
7.11.4 Cellectis SA Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.11.5 Cellectis SA Key News & Latest Developments
7.12 Bio-Techne
7.12.1 Bio-Techne Company Summary
7.12.2 Bio-Techne Business Overview
7.12.3 Bio-Techne Repeat Expansion Disorders Treatment Major Product Offerings
7.12.4 Bio-Techne Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.12.5 Bio-Techne Key News & Latest Developments
7.13 GlaxoSmithKline plc
7.13.1 GlaxoSmithKline plc Company Summary
7.13.2 GlaxoSmithKline plc Business Overview
7.13.3 GlaxoSmithKline plc Repeat Expansion Disorders Treatment Major Product Offerings
7.13.4 GlaxoSmithKline plc Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.13.5 GlaxoSmithKline plc Key News & Latest Developments
7.14 Allergan Aurobindo Pharma Ltd.
7.14.1 Allergan Aurobindo Pharma Ltd. Company Summary
7.14.2 Allergan Aurobindo Pharma Ltd. Business Overview
7.14.3 Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Major Product Offerings
7.14.4 Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.14.5 Allergan Aurobindo Pharma Ltd. Key News & Latest Developments
7.15 Sun Pharmaceutical Industries Ltd.
7.15.1 Sun Pharmaceutical Industries Ltd. Company Summary
7.15.2 Sun Pharmaceutical Industries Ltd. Business Overview
7.15.3 Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Major Product Offerings
7.15.4 Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.15.5 Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
7.16 Torrent Pharmaceuticals Ltd.
7.16.1 Torrent Pharmaceuticals Ltd. Company Summary
7.16.2 Torrent Pharmaceuticals Ltd. Business Overview
7.16.3 Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Major Product Offerings
7.16.4 Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.16.5 Torrent Pharmaceuticals Ltd. Key News & Latest Developments
7.17 Intas Pharmaceuticals Ltd.
7.17.1 Intas Pharmaceuticals Ltd. Company Summary
7.17.2 Intas Pharmaceuticals Ltd. Business Overview
7.17.3 Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Major Product Offerings
7.17.4 Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.17.5 Intas Pharmaceuticals Ltd. Key News & Latest Developments
7.18 Cipla Ltd
7.18.1 Cipla Ltd Company Summary
7.18.2 Cipla Ltd Business Overview
7.18.3 Cipla Ltd Repeat Expansion Disorders Treatment Major Product Offerings
7.18.4 Cipla Ltd Repeat Expansion Disorders Treatment Revenue in Global Market (2018-2023)
7.18.5 Cipla Ltd Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Repeat Expansion Disorders Treatment Market Opportunities & Trends in Global Market
Table 2. Repeat Expansion Disorders Treatment Market Drivers in Global Market
Table 3. Repeat Expansion Disorders Treatment Market Restraints in Global Market
Table 4. Key Players of Repeat Expansion Disorders Treatment in Global Market
Table 5. Top Repeat Expansion Disorders Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Repeat Expansion Disorders Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Repeat Expansion Disorders Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Repeat Expansion Disorders Treatment Product Type
Table 9. List of Global Tier 1 Repeat Expansion Disorders Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Repeat Expansion Disorders Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Repeat Expansion Disorders Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Repeat Expansion Disorders Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Repeat Expansion Disorders Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Repeat Expansion Disorders Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Repeat Expansion Disorders Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Repeat Expansion Disorders Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer, Inc. Company Summary
Table 31. Pfizer, Inc. Repeat Expansion Disorders Treatment Product Offerings
Table 32. Pfizer, Inc. Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer, Inc. Key News & Latest Developments
Table 34. CRISPR Therapeutics Company Summary
Table 35. CRISPR Therapeutics Repeat Expansion Disorders Treatment Product Offerings
Table 36. CRISPR Therapeutics Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. CRISPR Therapeutics Key News & Latest Developments
Table 38. Acorda Therapeutics Company Summary
Table 39. Acorda Therapeutics Repeat Expansion Disorders Treatment Product Offerings
Table 40. Acorda Therapeutics Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Acorda Therapeutics Key News & Latest Developments
Table 42. Capsida Biotherapeutics Inc. Company Summary
Table 43. Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Product Offerings
Table 44. Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Capsida Biotherapeutics Inc. Key News & Latest Developments
Table 46. Larimar Therapeutics, Inc. Company Summary
Table 47. Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Product Offerings
Table 48. Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Larimar Therapeutics, Inc. Key News & Latest Developments
Table 50. Healx, Intellia Therapeutics, Inc. Company Summary
Table 51. Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Product Offerings
Table 52. Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Healx, Intellia Therapeutics, Inc. Key News & Latest Developments
Table 54. Editas Medicine Company Summary
Table 55. Editas Medicine Repeat Expansion Disorders Treatment Product Offerings
Table 56. Editas Medicine Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Editas Medicine Key News & Latest Developments
Table 58. Bluebird bio, Inc. Company Summary
Table 59. Bluebird bio, Inc. Repeat Expansion Disorders Treatment Product Offerings
Table 60. Bluebird bio, Inc. Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Bluebird bio, Inc. Key News & Latest Developments
Table 62. Sanofi, Merck & Co., Inc. Company Summary
Table 63. Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Product Offerings
Table 64. Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Sanofi, Merck & Co., Inc. Key News & Latest Developments
Table 66. H. Lundbeck A/S Company Summary
Table 67. H. Lundbeck A/S Repeat Expansion Disorders Treatment Product Offerings
Table 68. H. Lundbeck A/S Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. H. Lundbeck A/S Key News & Latest Developments
Table 70. Cellectis SA Company Summary
Table 71. Cellectis SA Repeat Expansion Disorders Treatment Product Offerings
Table 72. Cellectis SA Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Cellectis SA Key News & Latest Developments
Table 74. Bio-Techne Company Summary
Table 75. Bio-Techne Repeat Expansion Disorders Treatment Product Offerings
Table 76. Bio-Techne Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Bio-Techne Key News & Latest Developments
Table 78. GlaxoSmithKline plc Company Summary
Table 79. GlaxoSmithKline plc Repeat Expansion Disorders Treatment Product Offerings
Table 80. GlaxoSmithKline plc Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. GlaxoSmithKline plc Key News & Latest Developments
Table 82. Allergan Aurobindo Pharma Ltd. Company Summary
Table 83. Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Product Offerings
Table 84. Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 85. Allergan Aurobindo Pharma Ltd. Key News & Latest Developments
Table 86. Sun Pharmaceutical Industries Ltd. Company Summary
Table 87. Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Product Offerings
Table 88. Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 89. Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 90. Torrent Pharmaceuticals Ltd. Company Summary
Table 91. Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Product Offerings
Table 92. Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 93. Torrent Pharmaceuticals Ltd. Key News & Latest Developments
Table 94. Intas Pharmaceuticals Ltd. Company Summary
Table 95. Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Product Offerings
Table 96. Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 97. Intas Pharmaceuticals Ltd. Key News & Latest Developments
Table 98. Cipla Ltd Company Summary
Table 99. Cipla Ltd Repeat Expansion Disorders Treatment Product Offerings
Table 100. Cipla Ltd Repeat Expansion Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 101. Cipla Ltd Key News & Latest Developments
List of Figures
Figure 1. Repeat Expansion Disorders Treatment Segment by Type in 2022
Figure 2. Repeat Expansion Disorders Treatment Segment by Application in 2022
Figure 3. Global Repeat Expansion Disorders Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Repeat Expansion Disorders Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Repeat Expansion Disorders Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Repeat Expansion Disorders Treatment Revenue in 2022
Figure 8. By Type - Global Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
Figure 16. US Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
Figure 28. China Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Repeat Expansion Disorders Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Repeat Expansion Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer, Inc. Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. CRISPR Therapeutics Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Acorda Therapeutics Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Editas Medicine Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bluebird bio, Inc. Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. H. Lundbeck A/S Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Cellectis SA Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bio-Techne Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. GlaxoSmithKline plc Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Cipla Ltd Repeat Expansion Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
